These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35573514)

  • 1. An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists.
    Kang CY; Khamooshi P; Reyes Pinzon V
    Cureus; 2022 Apr; 14(4):e24016. PubMed ID: 35573514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
    Bteich F; Daher G; Kapoor A; Charbek E; Kamel G
    Cureus; 2019 Apr; 11(4):e4496. PubMed ID: 31259114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
    Chou YM; Seak CJ; Goh ZNL; Seak JC; Seak CK; Lin CC
    Medicine (Baltimore); 2018 Jun; 97(25):e11056. PubMed ID: 29923997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports.
    Altowayan WM
    Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
    Zughaib MT; Patel K; Leka M; Affas S
    Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
    Kamath SD; Kumar U; Shrivastava V
    Cureus; 2024 Apr; 16(4):e58341. PubMed ID: 38756291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.
    Long B; Lentz S; Koyfman A; Gottlieb M
    Am J Emerg Med; 2021 Jun; 44():157-160. PubMed ID: 33626481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis.
    Iqbal I; Hamid M; Khan MAA; Kainat A; Tariq S
    Cureus; 2019 Nov; 11(11):e6089. PubMed ID: 31857921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports.
    Juneja D; Nasa P; Jain R; Singh O
    World J Diabetes; 2023 Aug; 14(8):1314-1322. PubMed ID: 37664476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
    Andrews TJ; Cox RD; Parker C; Kolb J
    J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.
    Somagutta MR; Agadi K; Hange N; Jain MS; Batti E; Emuze BO; Amos-Arowoshegbe EO; Popescu S; Hanan S; Kumar VR; Pormento K
    Cureus; 2021 Mar; 13(3):e13665. PubMed ID: 33824816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report.
    Alkatheeri A; Alseddeeqi E
    J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review.
    Kapila V; Topf J
    Cureus; 2021 Aug; 13(8):e17093. PubMed ID: 34527480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians?
    Somagutta MKR; Uday U; Shama N; Bathula NR; Pendyala S; Mahadevaiah A; Mahmutaj G; Ngardig NN
    Korean J Fam Med; 2022 Nov; 43(6):361-366. PubMed ID: 36444120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Rao SJ; Kumar K; Saleh N
    Cureus; 2022 Oct; 14(10):e30106. PubMed ID: 36381906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
    Gajjar K; Luthra P
    Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Severe Metabolic Acidosis due to Jardiance-Induced Euglycemic Diabetic Ketoacidosis.
    Dyatlova N; Omotosho YB; Sherchan R; Shrestha J; Buddharaju V
    Cureus; 2021 Apr; 13(4):e14580. PubMed ID: 33889468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
    Seger CD; Xing H; Wang L; Shin JS
    A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.
    Chow E; Clement S; Garg R
    BMJ Open Diabetes Res Care; 2023 Oct; 11(5):. PubMed ID: 37797963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.